-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2020 to Q3 2025.
- Nurix Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 31 Aug 2025 was -1.03 USD/shares, a 53.7% decline year-over-year.
- Nurix Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 31 Aug 2025 was -2 USD/shares, a 1.72% decline year-over-year.
- Nurix Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -2.88 USD/shares, a 8.68% decline from 2023.
- Nurix Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.65 USD/shares, a 28.6% increase from 2022.
- Nurix Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.71 USD/shares, a 35.9% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)